Dietary non-digestible polysaccharides ameliorate intestinal epithelial barrier dysfunction in IL-10 knockout mice

Journal of Crohn's and Colitis

Volumn 10, Issue 9, 2016, Pages 1076-1086

  Wang, Honggang ^a,b   Shi, Peiliang ^c   Zuo, Lugen ^b   Dong, Jianning ^b,d   Zhao, Jie ^b   Liu, Qinghong ^a   Zhu, Weiming ^b  

^a NANTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Barrier function; IL 10 knockout; Multi fibre mix; Regulatory T cells; Short chain fatty acids; Tight junction

Indexed keywords

ACETIC ACID; BUTYRIC ACID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; OCCLUDIN; POLYSACCHARIDE; PROPIONIC ACID; PROTEIN ZO1; SHORT CHAIN FATTY ACID; STAT3 PROTEIN; STAT4 PROTEIN; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; PREBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASCENDING COLON; CD4+ T LYMPHOCYTE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERIC FEEDING; ENTEROPATHY; INTESTINAL EPITHELIAL BARRIER DYSFUNCTION; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; COLON; DEFICIENCY; DIET THERAPY; DIETARY FIBER; EVALUATION STUDY; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PERMEABILITY; PROCEDURES; SEVERITY OF ILLNESS INDEX; THERAPEUTIC USE; TIGHT JUNCTION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BIOMARKERS; COLITIS; COLON; DIETARY FIBER; ENTERAL NUTRITION; INTERLEUKIN-10; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERMEABILITY; POLYSACCHARIDES; PREBIOTICS; SEVERITY OF ILLNESS INDEX; TIGHT JUNCTIONS; TREATMENT OUTCOME;

EID: 85012301061     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjw065     Document Type: Article

References (40)

1. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010;10:170-81.
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573-621.
3. Azuma T, Shigeshiro M, Kodama M, Tanabe S, Suzuki T. Supplemental naringenin prevents intestinal barrier defects and inflammation in colitic mice. J Nutr 2013;143:827-34.
4. Izcue A, Coombes JL, Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009;27:313-38.
5. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306.
6. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
7. Su L, Nalle SC, Shen L, et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 2013;145:407-15.
8. Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013;504:446-50.
9. Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011;469:543-7.
10. Wang H, Zhang W, Zuo L, et al. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr 2013;109:1990-8.
11. Azzopardi N, Ellul P. Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset. Inflamm Bowel Dis 2013;19:1173-8.
12. Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 2005;11:580-8.
13. Li Y, Zhu W, Gong J, et al. Influence of exclusive enteral nutrition therapy on visceral fat in patients with Crohn's disease. Inflamm Bowel Dis 2014;20:1568-74.
14. Zhao J, Dong JN, Gong JF, et al. Impact of enteral nutrition on energy metabolism in patients with Crohn's disease. World J Gastroenterol 2015;21:1299-304.
15. Zuo L, Li Y, Wang H, et al. A practical predictive index for intra-abdominal septic complications after primary anastomosis for Crohn's disease: Change in C-reactive protein level before surgery. Dis Colon Rectum 2015;58:775-81.
16. Day AS, Burgess L. Exclusive enteral nutrition and induction of remission of active Crohn's disease in children. Expert Rev Clin Immunol 2013;9:375-83; quiz 384.
17. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF Jr, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004;34:2690-8.
18. Spencer DM, Veldman GM, Banerjee S, Willis J, Levine AD. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology 2002;122:94-105.
19. Singh UP, Singh NP, Singh B, Price RL, Nagarkatti M, Nagarkatti PS. Cannabinoid receptor-2 [CB2] agonist ameliorates colitis in IL-10[-/-] mice by attenuating the activation of T cells and promoting their apoptosis. Toxicol Appl Pharmacol 2012;258:256-67.
20. Salazar N, Gueimonde M, Hernandez-Barranco AM, Ruas-Madiedo P, de los Reyes-Gavilan CG. Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Appl Environ Microbiol 2008;74:4737-45.
21. Wang H, Dong J, Zuo L, et al. Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice. Br J Nutr 2014;111:987-95.
22. Zhao J, Sun Y, Shi P, et al. Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy. Int Immunopharmacol 2015;26:221-8.
23. Wang H, Dong J, Shi P, et al. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis. Immunology 2015;144:254-62.
24. Looijer-van LM, Hotte N, Dieleman LA, Albert E, Mulder C, Madsen KL. Estrogen receptor-beta signaling modulates epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 2011;300:G6216.
25. Dong J, Wang H, Zhao J, et al. SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice. Immunol Res 2015;61:303-11.
26. Dong J, Wang H, Wu G, et al. Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice. Clin Exp Immunol 2014;177:94-101.
27. Mathur AN, Chang HC, Zisoulis DG, et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007;178:4901-7.
28. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007;56:61-72.
29. Juric M, Xiao F, Amasheh S, et al. Increased epithelial permeability is the primary cause for bicarbonate loss in inflamed murine colon. Inflamm Bowel Dis 2013;19:904-11.
30. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014;63:1275-83.
31. Hartog A, Belle FN, Bastiaans J, et al. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides. J Nutr Biochem 2015;26:227-33.
32. Joo E, Yamane S, Hamasaki A, et al. Enteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in mice. Nutrition 2013;29:549-55.
33. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol 2002;37[Suppl 14]:67-72.
34. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: metaanalysis of randomized controlled trials. Inflamm Bowel Dis 2014;20:21-35.
35. Schneider SM, Girard-Pipau F, Anty R, et al. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota. Clin Nutr 2006;25:82-90.
36. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306.
37. Becker C, Watson AJ, Neurath MF. Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 2013;144:283-93.
38. Waschke KA, Villani AC, Vermeire S, et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol 2005;100:1126-33.
39. Wang F, Schwarz BT, Graham WV, et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 2006;131:1153-63.
40. Poritz LS, Harris LR 3rd, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 2011;56:2802-9.